Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting Club
PRO
LivestreamMenuCheck out the companies making the biggest moves midday: IES Holdings — Shares were up over 30% after the electrical services company posted better-than-expected quarterly results. IES’ board also recently approved a two-for-one split of its common stock, which would be paid as a stock dividend. GoDaddy – Shares of the website domain provider tanked 20% after the company issued guidance that underwhelmed Wall Street. GoDaddy reaffirmed free cash flow of about $1.8 billion for the full year, roughly in line with the FactSet consensus call for $1.81 billion. Revenue for the period is expected to range from $5.215 to $5.255 billion, versus the consensus estimate of $5.24 billion. Cash flow of about $444 million for the latest quarter came in sharply below the consensus estimate of $473 million, per LSEG. Newell Brands – The owner of Rubbermaid food storage products and Graco baby gear rose 11%. Newell lifted guidance for the full year, calling for earnings of 73 cents to 77 cents per share, up from its earlier forecast of 56 cents to 60 cents per share. The outlook also surpassed the FactSet consensus estimate of 58 cents per share. SPX Technologies — The power boiler maker rallied 14% on second-quarter results that exceeded analyst expectations. SPX Technologies also raised its full-year earnings and revenue outlook. Veracyte — Shares of the global diagnostics company fell 24% after Veracyte’s latest financial results failed to impress investors despite exceeding analyst expectations. In addition to adjusted earnings and revenue coming in above the consensus estimates, the company also raised its full-year revenue guidance. Shares had moved 7% higher Thursday ahead of the earnings release. Replimune Group — Shares were up over 94% for the clinical-stage biotechnology company after a Food and Drug Administration advisory panel voted in favor of the company’s RP1 drug trial results for a type of skin cancer. Wedbush Securities upgraded Replimune Group to outperform from neutral following the decision. Jersey Mike’s — Shares were up 6% after the sandwich restaurant chain made its public debut on Thursday. Jersey Mike’s opened at $21 per share , a dip from its public offering price of $23 per share. It closed with a 6% fall the day of its debut. Chevron — Shares were rose 1.6% after the energy giant reported better-than-expected earnings and revenue for the second quarter. Chevron recorded $12.1 billion in net income, a nearly 400% increase from the same period last year. ExxonMobil — Shares fell 2% after the energy giant reported weaker-than-expected earnings for the second quarter. The company earned an adjusted $3.52 per share, while analysts polled by LSEG expected a profit of $3.60 per share. Moderna — The biotech giant dropped 1% despite the company posting second-quarter results that beat the Street. Moderna lost $1.97 per share on revenue of $145 million. Analysts expected a loss of $2.03 per share on revenue of $102.9 million. Full-year revenue guidance was also above expectations. Amazon — The e-commerce giant’s shares shot up 15% after the firm reported better-than-expected revenue and cloud growth for the second quarter on Thursday. Revenue in Amazon’s cloud segment expanded 37% year over year during the quarter, surpassing Wall Street’s expectations for 31% growth and marking the unit’s fastest growth in 18 quarters. Apple — The tech giant saw shares fall more than 9% after it reported stronger-than-expected revenue for the fiscal third quarter, driven by a 22% increase in iPhone sales. Coinbase — The crypto exchange slid more than 12% after posting its third straight quarterly loss . The company reported a loss of $359.5 million, or $1.36 per share, while analysts had anticipated a loss of 17 cents a share. Revenue of $1.22 billion was shy of the $1.31 billion estimate. Reddit — The social media platform’s shares dropped 22%, underscoring Wall Street’s concerns about the company’s search-referral traffic from Google. CEO Steve Huffman said search referrals were “choppy” in the quarter. The company did report second-quarter earnings that beat on the top and the bottom lines, while issuing guidance that sailed past expectations. Novo Nordisk — Shares fell 9% after phase 3 trial results for its drug ziltivekimab failed to reduce major cardiovascular events compared to placebo. — CNBC’s Darla Mercado and Michelle Fox contributed reporting.
About The Author
